Phibro Animal Health (PAHC) Tops Q2 EPS by 4c, Reaffirms FY17 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips below $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Phibro Animal Health Corporation Reports Second Quarter
February 6, 2017 4:15 PM ESTTEANECK, N.J., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its second quarter ended December 31, 2016.
Highlights for the December 2016 quarter (compared to the December 2015 quarter)
Net sales of $192 million, equal to the prior yearNet income of $13 million, a decrease of $16.8 million, or 56%Diluted EPS of $0.34, a decrease of $0.41, or 56%Adjusted EBITDA of $31 million, an increase of $3 million, or 10%Adjusted diluted EPS of $0.39, an increase of $0.02, or 5%ÂCOMMENTARY
We are very... More
